|
1.
|
Neyestanaki DK, Mirsalehian A,
Rezagholizadeh F, Jabalameli F, Taherikalani M and Emaneini M:
Determination of extended spectrum beta-lactamases,
metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem
resistant Pseudomonas aeruginosa isolated from burn
patients. Burns. 40:1556–1561. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Gupta G, Tak V and Mathur P: Detection of
AmpC β lactamases in gram-negative bacteria. J Lab Physicians.
6:1–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Belas A, Salazar AS, Gama LT, Couto N and
Pomba C: Risk factors for faecal colonisation with Escherichia
coli producing extended-spectrum and plasmid-mediated AmpC
β-lactamases in dogs. Vet Rec. 175:2022014. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Wassef M, Behiry I, Younan M, El Guindy N,
Mostafa S and Abada E: Genotypic identification of AmpC
β-lactamases production in gram-negative bacilli isolates.
Jundishapur J Microbiol. 7:e85562014. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Balıkçı H, Açıkgöz ZC, Güvenman S,
Celikbilek N and Ozdem B: Detection of plasmid-mediated AmpC
beta-lactamase production in Escherichia coli and
Klebsiella spp. isolates. Mikrobiyol Bul. 48:82–93. 2014.(In
Turkish). PubMed/NCBI
|
|
6.
|
Paltansing S, Kraakman M, van Boxtel R,
Kors I, Wessels E, Goessens W, Tommassen J and Bernards A:
Increased expression levels of chromosomal AmpC β-lactamase in
clinical Escherichia coli isolates and their effect on
susceptibility to extended-spectrum cephalosporins. Microb Drug
Resist. 21:7–16. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Helmy MM and Wasfi R: Phenotypic and
molecular characterization of plasmid mediated AmpC β-lactamases
among Escherichia coli, Klebsiella spp., and
Proteus mirabilis isolated from urinary tract infections in
Egyptian hospitals. Biomed Res Int. 2014:1715482014. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Mohamudha PR, Harish BN and Parija SC:
Molecular description of plasmid-mediated AmpC β-lactamases among
nosocomial isolates of Escherichia coli & Klebsiella
pneumoniae from six different hospitals in India. Indian J Med
Res. 135:114–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Grover N, Sahni AK and Bhattacharya S:
Therapeutic challenges of ESBLS and AmpC beta-lactamase producers
in a tertiary care center. Med J Armed Forces India. 69:4–10. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Jones-Dias D, Manageiro V, Ferreira E and
Louro D: Antibiotic Resistance Surveillance Program in Portugal
(ARSIP) participants; Caniça M: Diversity of extended-spectrum and
plasmid-mediated AmpC β-lactamases in Enterobacteriaceae isolates
from Portuguese health care facilities. J Microbiol. 52:496–503.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Singla P, Sikka R, Deeep A, Gagneja D and
Chaudhary U: Co-production of ESBL and AmpC β-lactamases in
clinical isolates of A. baumannii and A. lwoffii in a
tertiary care hospital from northern India. J Clin Diagn Res.
8:DC16–DC19. 2014.PubMed/NCBI
|
|
12.
|
Begum S, Hasan F, Hussain S and Ali Shah
A: Prevalence of multi drug resistant Acinetobacter
baumannii in the clinical samples from tertiary care hospital
in Islamabad, Pakistan. Pak J Med Sci. 29:1253–1258.
2013.PubMed/NCBI
|
|
13.
|
Freitas F, Machado E, Ribeiro TG, Novais Â
and Peixe L: Long-term dissemination of acquired AmpC β-lactamases
among Klebsiella spp. and Escherichia coli in
Portuguese clinical settings. Eur J Clin Microbiol Infect Dis.
33:551–558. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Tugal D, Lynch M, Hujer AM, Rudin S, Perez
F and Bonomo RA: Multi-drug-resistant Klebsiella pneumoniae
pancreatitis: A new challenge in a serious surgical infection. Surg
Infect (Larchmt). 16:188–193. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Souna D, Amir AS, Bekhoucha SN, Berrazeg M
and Drissi M: Molecular typing and characterization of TEM, SHV,
CTX-M, and CMY-2 β-lactamases in Enterobacter cloacae
strains isolated in patients and their hospital environment in the
west of Algeria. Med Mal Infect. 44:146–152. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Qin X, Zerr DM, Weissman SJ, Englund JA,
Denno DM, Klein EJ, Tarr PI, Kwong J, Stapp JR, Tulloch LG and
Galanakis E: Prevalence and mechanisms of broad-spectrum
beta-lactam resistance in Enterobacteriaceae: A children's hospital
experience. Antimicrob Agents Chemother. 52:3909–3914. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Andrews JM BSAC Working Party On
Susceptibility Testing ft: BSAC standardized disc susceptibility
testing method. J Antimicrob Chemother. 48:43–57. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Pérez-Pérez FJ and Hanson ND: Detection of
plasmid-mediated AmpC beta-lactamase genes in clinical isolates by
using multiplex PCR. J Clin Microbiol. 40:2153–2162. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Nicola FG, Nievas J and Smayevsky J:
Evaluation of phenotypic methods for the detection of KPC
carbapenemases in Klebsiella pneumoniae. Rev Argent
Microbiol. 44:290–302. 2012.(In Spanish). PubMed/NCBI
|
|
20.
|
Reardon S: Antibiotic resistance sweeping
developing world. Nature. 509:141–142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Voets GM, Platteel TN, Fluit AC,
Scharringa J, Schapendonk CM, Stuart JC, Bonten MJ and Hall MA:
National ESBL Surveillance Working Group: Population distribution
of beta-lactamase conferring resistance to third-generation
cephalosporins in human clinical Enterobacteriaceae in the
Netherlands. PLoS One. 7:e521022012. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Bonnedahl J, Hernandez J, Stedt J,
Waldenström J, Olsen B and Drobni M: Extended-spectrum β-lactamases
in Escherichia coli and Klebsiella pneumoniae in
Gulls, Alaska, USA. Emerg Infect Dis. 20:897–899. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Markovska R, Schneider I, Marteva-Proevsk
Y, Mitov I, Barernfeind A and Markova B: First detection of the
AmpC beta-lactamase ACC-1 in a Klebsiella pneumoniae isolate
in Bulgaria. J Chemother. 24:307–308. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Shanthi J and Balagurunathan R:
Characterisation of heteroresistant subcolonies for MBL, AmpC genes
in Klebsiella pneumoniae and Acinetobacter baumannii.
Indian J Med Microbiol. 32:210–211. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Brenwald NP, Andrews J and Fraise AP:
Activity of mecillinam against AmpC beta-lactamase-producing
Escherichia coli. J Antimicrob Chemother. 58:223–224. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Pai H, Kang CI, Byeon JH, Lee KD, Park WB,
Kim HB, Kim EC, Oh MD and Choe KW: Epidemiology and clinical
features of bloodstream infections caused by
AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.
Antimicrob Agents Chemother. 48:3720–3728. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Rao SP, Rama PS, Gurushanthappa V,
Manipura R and Srinivasan K: Extended-spectrum beta-lactamases
producing Escherichia coli and Klebsiella pneumoniae:
A multi-centric study across Karnataka. J Lab Physicians. 6:7–13.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Shafiq M, Rahman H, Qasim M, Ayub N,
Hussain S, Khan J and Naeem M: Prevalence of plasmid-mediated AmpC
β-lactamases in Escherichia coli and Klebsiella
pneumonia at tertiary care hospital of Islamabad, Pakistan. Eur
J Microbiol Immunol (Bp). 3:267–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Ding H, Yang Y, Lu Q, Wang Y, Chen Y, Deng
L, Wang A, Deng Q, Zhang H, Wang C, et al: The prevalence of
plasmid-mediated AmpC beta-lactamases among clinical isolates of
Escherichia coli and Klebsiella pneumoniae from five
children's hospitals in China. Eur J Clin Microbiol Infect Dis.
27:915–921. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Alvarez M, Tran JH, Chow N and Jacoby GA:
Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases
in the United States. Antimicrob Agents Chemother. 48:533–537.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Peng JH, Sun ZY, Zhou YL and Lv J: Study
on the gene type of plasmid AmpC enzyme producing Klebsiella
pneumonia. Zhong Hua Yi Yuan Gan Ran Xue Za Zhi. 17:1072–1075.
2007.(In Chinese).
|
|
32.
|
Shi W, Li K, Ji Y, Jiang Q, Wang Y, Shi M
and Mi Z: Carbapenem and cefoxitin resistance of Klebsiella
pneumoniae strains associated with porin OmpK36 loss and DHA-1
β-lactamase production. Braz J Microbiol. 44:435–442. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33.
|
Shi WF, Zhou J and Qin JP:
Transconjugation and genotyping of the plasmid-mediated AmpC
beta-lactamase and extended-spectrum beta-lactamase genes in
Klebsiella pneumoniae. Chin Med J (Engl). 122:1092–1096.
2009.PubMed/NCBI
|
|
34.
|
Queenan AM and Bush K: Carbapenemases: The
versatile beta-lactamases. Clin Microbiol Rev. 20:440–458. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
35.
|
Yigit H, Queenan AM, Anderson GJ, et al:
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a
carbapenem-resistant strain of Klebsiella pneumonia.
Antimicrob Agents Ch. 45:1151–1161. 2001. View Article : Google Scholar
|
|
36.
|
Zhao SP, Jiang MJ and Zong GZ: Comparison
of detection methods for drug sensitivity of KPC-producing
Klebsiella pneumonia. Zhong Hua Shi Yan He Lin Chuang Gan
Ran Bing Za Zhi. 6:5–7. 2012.
|
